PD-161314

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NamePD-161314

Drug Alias NamePD-161314

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics

Mechanisms of ActionBacterial DNA gyrase inhibitors

TargetsBacterial DNA gyrase

Therapy Area/IndicationsMycobacterium avium-intracellulare Infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsMycobacterium avium-intracellulare Infection

ATC CodeN/A